Exchange: NASDAQ·Updated 07:48 PM EDT
APVO logo

APVO Aptevo Therapeutics Inc

$2.34
$0.10
(4.10%)
Today
Closed $2.34
$0.05
(2.14%)
After Hours
Mkt Cap$4.4M
Vol31,994.00

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
62

Bullish Sentiment

How do you feel about APVO?

Advertisement|Remove ads.